Eric Werlinger | Katten Muchin Rosenman LLP

Eric Werlinger

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Experience10 yrs

Elite Ratings

DCT,

PTAB,

CAFC

Practice Areas

Communications (150 cases)

Biotech (140 cases)

Design (130 cases)

Law Firms

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Experience

Grade

Trend

DCT

PTAB

CAFC

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Case #	Appeal From	Caption	Decision	Represent
20-0001	2:18-cv-00734 2:19-cv-16484	Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc.	04/01/24	Patent Owner : Samsung Electronics Co Ltd
20-0002	1:21-cv-01256	Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC	01/16/24	Challenger (L) : Apple Inc
20-0003	1:20-cv-00110	Actelion Pharmaceuticals Ltd v. Mylan Pharmaceuticals Inc.	11/06/23	Patent Owner : Google LLC
20-0004	1:19-cv-00474	UCB, Inc. v. Actavis Laboratories UT, Inc.	04/12/23	Challenger (W) : Microsoft Corp
20-0005	2:19-cv-00128	UCB, Inc. v. Mylan Technologies Inc.	04/12/23	Patent Owner (L) : LG Electronics Inc
20-0006	IPR2020-00040	Mylan Pharmaceuticals Inc. v. Merck Sharp & Dohme Corp.	09/29/22	Challenger : Facebook Inc
20-0007	IPR2019-01233	directPacket Research, Inc. v. Polycom, Inc.	01/26/22	Patent Owner (W) : Intel Corp
20-0008	IPR2019-01234	Polycom, Inc. v. directPacket Research, Inc.	12/13/21	Challenger (W) : Uniloc USA Inc
20-0009	3:15-cv-05982 3:16-cv-00851 3:16-cv-00852 3:16-cv-01727 3:16-cv-02394	BOEHRINGER INGELHEIM v. MYLAN LABORATORIES	03/16/20	Patent Owner : Sony Corp
20-0010	2:20-cv-13103	Janssen Pharmaceuticals, Inc. v. Mylan Laboratories Ltd.		Challenger (L) : Cisco Systems Inc